ZENTALIS PHARMACEUTICA

Zentalis Pharmaceuticals Reports Full Year 2022 Financial Results and Operational Updates

01 مارس 2023 04:00:01 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Appoints Dr. Iris Roth as Chief Operating Officer

13 فبراير 2023 04:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01 فبراير 2023 14:00:41 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences

01 فبراير 2023 04:01:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 يناير 2023 14:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 ديسمبر 2022 14:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates

09 نوفمبر 2022 04:00:02 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in the Stifel 2022 Healthcare Conference

08 نوفمبر 2022 04:01:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 نوفمبر 2022 14:38:22 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces First ZN-c3 Clinical Development Collaboration with Pfizer

24 أكتوبر 2022 04:00:01 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Appoints Dr. Mark Lackner as Chief Translational Officer, Head of Biomarker Strategy

17 أكتوبر 2022 04:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 أكتوبر 2022 14:32:42 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Promotes Co-Founder Kevin Bunker, Ph.D. to Chief Scientific Officer

27 سبتمبر 2022 13:01:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Appoints Dr. Carrie Brownstein as Chief Medical Officer

19 سبتمبر 2022 04:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Appoints Dr. Jan Skvarka to its Board of Directors

12 سبتمبر 2022 04:00:01 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01 سبتمبر 2022 14:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences

31 أغسطس 2022 04:00:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update

09 أغسطس 2022 13:01:00 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in the Wedbush PacGrow Healthcare Conference

03 أغسطس 2022 04:00:01 بحسب Nasdaq GlobeNewswire

Zentalis Pharmaceuticals, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01 أغسطس 2022 14:10:35 بحسب Nasdaq GlobeNewswire